{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:29:48Z","timestamp":1791426588922,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["S0008\u20132009\u20131-115250"],"award-info":[{"award-number":["S0008\u20132009\u20131-115250"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Whether the metabolically healthy obese (MHO) phenotype is a single, stable or a transitional, fluctuating state is currently unknown. The Mexican-Mestizo population has a genetic predisposition for the development of type 2 diabetes (T2D) and other cardiometabolic complications. Little is known about the natural history of metabolic health in this population. The aim of this study was to analyze the transitions over time among individuals with different degrees of metabolic health and body mass index, and evaluate the incidence of cardiometabolic outcomes according to phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study population consisted of a metabolic syndrome cohort with at least 3 years of follow up. Participants were apparently-healthy urban Mexican adults \u226520\u2009years with a body mass index (BMI) \u226520\u2009kg\/m2. Metabolically healthy phenotype was defined using the criteria of the National Cholesterol Education Program (\n                      <jats:italic>NCEP<\/jats:italic>\n                      ) Adult Treatment Panel III (\n                      <jats:italic>ATP III<\/jats:italic>\n                      ) metabolic syndrome criteria and the subjects were stratified into 4 groups according to their BMI and metabolic health. For cardiometabolic outcomes we estimated the incidence of cardiometabolic outcomes and standardized them per 1, 000 person-years of follow-up. Finally, to evaluate the risk for transition and development of cardiometabolic outcomes, we fitted Cox Proportional Hazard regression models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Amongst the 5541 subjects, 54.2% were classified as metabolically healthy and 45.8% as unhealthy. The MHO prevalence was 39.3%. Up to a third of the population changed from their initial category to another and the higher transition rate was observed in MHO (42.9%). We also found several novel factors associated to transition to metabolically unhealthy phenotype; socioeconomic status, number of pregnancies, a high carbohydrate intake, history of obesity and consumption of sweetened beverages. Similarly, visceral adipose tissue (VAT) was a main predictor of transition; loss of VAT \u22655% was associated with reversion from metabolically unhealthy to metabolically healthy phenotype (hazard ratio (HR) 1.545, 95%CI 1.266\u20131.886). Finally, we observed higher incidence rates and risk of incident T2D and hypertension in the metabolically unhealthy obesity (MUHO) and metabolically unhealthy lean (MUHL) phenotypes compared to MHO.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Metabolic health is a dynamic and continuous process, at high risk of transition to metabolically unhealthy phenotypes over time. It is imperative to establish effective processes in primary care to prevent such transitions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-021-00754-1","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T03:06:30Z","timestamp":1619579190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study"],"prefix":"10.1186","volume":"21","author":[{"name":"for the Metabolic Syndrome Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"El\u00edas-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsenio","family":"Vargas-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette","family":"Cruz Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Del Razo Olvera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donaji","family":"G\u00f3mez-Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Almeda Valdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-0241","authenticated-orcid":false,"given":"Carlos A.","family":"Aguilar-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"issue":"3","key":"754_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ecl.2016.04.004","volume":"45","author":"T Kyle","year":"2016","unstructured":"Kyle T, Dhurandhar E, Allison D. Regarding obesity as a disease. Endocrinol Metab Clin N Am. 2016;45(3):511\u201320. https:\/\/doi.org\/10.1016\/j.ecl.2016.04.004.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"754_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.metabol.2018.10.007","volume":"92","author":"K Rohde","year":"2019","unstructured":"Rohde K, Keller M, la Cour PL, Bl\u00fcher M, Kovacs P, B\u00f6ttcher Y. Genetics and epigenetics in obesity. Metabolism. 2019;92:37\u201350. https:\/\/doi.org\/10.1016\/j.metabol.2018.10.007.","journal-title":"Metabolism"},{"issue":"10031","key":"754_CR3","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/S0140-6736(16)00271-3","volume":"387","author":"G Bray","year":"2016","unstructured":"Bray G, Fr\u00fchbeck G, Ryan D, Wilding J. Management of obesity. Lancet. 2016;387(10031):1947\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(16)00271-3.","journal-title":"Lancet"},{"issue":"3","key":"754_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/endrev\/bnaa004","volume":"41","author":"M Bl\u00fcher","year":"2020","unstructured":"Bl\u00fcher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3):405\u201320.","journal-title":"Endocr Rev"},{"issue":"10","key":"754_CR5","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1172\/JCI129186","volume":"129","author":"G Smith","year":"2019","unstructured":"Smith G, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Investig. 2019;129(10):3978\u201389. https:\/\/doi.org\/10.1172\/JCI129186.","journal-title":"J Clin Investig"},{"issue":"10","key":"754_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/obr.12198","volume":"15","author":"J Rey-L\u00f3pez","year":"2014","unstructured":"Rey-L\u00f3pez J, de Rezende L, Pastor-Valero M, Tess B. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014;15(10):781\u201390. https:\/\/doi.org\/10.1111\/obr.12198.","journal-title":"Obes Rev"},{"issue":"8","key":"754_CR7","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.2337\/dc12-1654","volume":"36","author":"G Hinnouho","year":"2013","unstructured":"Hinnouho G, Czernichow S, Dugravot A, Batty G, Kivimaki M, Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care. 2013;36(8):2294\u2013300. https:\/\/doi.org\/10.2337\/dc12-1654.","journal-title":"Diabetes Care"},{"key":"754_CR8","doi-asserted-by":"publisher","unstructured":"Primeau, V., Coderre, L., Karelis, A. et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes 35, 971\u2013981 (2011). https:\/\/doi.org\/https:\/\/doi.org\/10.1038\/ijo.2010.216, 7.","DOI":"10.1038\/ijo.2010.216"},{"issue":"9","key":"754_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/eurheartj\/ehu123","volume":"36","author":"G Hinnouho","year":"2014","unstructured":"Hinnouho G, Czernichow S, Dugravot A, Nabi H, Brunner E, Kivimaki M, et al. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J. 2014;36(9):551\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehu123.","journal-title":"Eur Heart J"},{"issue":"11","key":"754_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","volume":"159","author":"C Kramer","year":"2013","unstructured":"Kramer C, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? Ann Intern Med. 2013;159(11):758\u201369. https:\/\/doi.org\/10.7326\/0003-4819-159-11-201312030-00008.","journal-title":"Ann Intern Med"},{"issue":"6","key":"754_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/obr.12157","volume":"15","author":"J Bell","year":"2014","unstructured":"Bell J, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014;15(6):504\u201315. https:\/\/doi.org\/10.1111\/obr.12157.","journal-title":"Obes Rev"},{"issue":"2","key":"754_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1210\/jc.2013-2832","volume":"99","author":"K Aung","year":"2014","unstructured":"Aung K, Lorenzo C, Hinojosa M, Haffner S. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy Normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99(2):462\u20138. https:\/\/doi.org\/10.1210\/jc.2013-2832.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"754_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ijo.2014.176","volume":"39","author":"R Eshtiaghi","year":"2014","unstructured":"Eshtiaghi R, Keihani S, Hosseinpanah F, Barzin M, Azizi F. Natural course of metabolically healthy abdominal obese adults after 10 years of follow-up: the Tehran lipid and glucose study. Int J Obes. 2014;39(3):514\u20139.","journal-title":"Int J Obes"},{"issue":"7","key":"754_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/nu8070430","volume":"8","author":"R Zheng","year":"2016","unstructured":"Zheng R, Liu C, Wang C, Zhou B, Liu Y, Pan F, et al. Natural course of metabolically healthy overweight\/obese subjects and the impact of weight change. Nutrients. 2016;8(7):430. https:\/\/doi.org\/10.3390\/nu8070430.","journal-title":"Nutrients"},{"issue":"3","key":"754_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s10038-020-00824-7","volume":"66","author":"JA Aguilar-Vel\u00e1zquez","year":"2021","unstructured":"Aguilar-Vel\u00e1zquez JA, Rangel-Villalobos H. Distribution of paternal lineages in mestizo populations throughout Mexico: an in silico study based on Y-STR haplotypes. J Hum Genet. 2021;66(3):327\u201332. https:\/\/doi.org\/10.1038\/s10038-020-00824-7.","journal-title":"J Hum Genet"},{"key":"754_CR16","doi-asserted-by":"publisher","unstructured":"Arellano-Campos O, G\u00f3mez-Velasco DV, Bello-Chavolla OY, et al. Development and validation of a predictive model for incident type 2 diabetes in middle-aged Mexican adults: the metabolic syndrome cohort. BMC Endocr Disord. 2019;19(1):41. https:\/\/doi.org\/10.1186\/s12902-019-0361-8.","DOI":"10.1186\/s12902-019-0361-8"},{"issue":"1","key":"754_CR17","first-page":"21","volume":"34","author":"C Medina","year":"2013","unstructured":"Medina C, Barquera S, Janssen I. Validity and reliability of the international physical activity questionnaire among adults in Mexico. Rev Panam Salud Publica. 2013;34(1):21\u20138.","journal-title":"Rev Panam Salud Publica"},{"issue":"5","key":"754_CR18","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","volume":"39","author":"O Bello-Chavolla","year":"2020","unstructured":"Bello-Chavolla O, Antonio-Villa N, Vargas-V\u00e1zquez A, Viveros-Ruiz T, Almeda-Valdes P, Gomez-Velasco D, et al. Metabolic score for visceral fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health. Clin Nutr. 2020;39(5):1613\u201321. https:\/\/doi.org\/10.1016\/j.clnu.2019.07.012.","journal-title":"Clin Nutr"},{"key":"754_CR19","doi-asserted-by":"publisher","unstructured":"Bello-Chavolla O, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533\u201344. https:\/\/doi.org\/10.1530\/EJE-17-0883.","DOI":"10.1530\/EJE-17-0883"},{"issue":"17","key":"754_CR20","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"S Grundy","year":"2005","unstructured":"Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B, et al. Diagnosis and Management of the Metabolic Syndrome an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.169404.","journal-title":"Circulation"},{"key":"754_CR21","unstructured":"[Internet]. Ensanut.insp.mx. 2020 [Cited 28 august 2020]. Available from: https:\/\/ensanut.insp.mx\/encuestas\/ensanut2018\/doctos\/informes\/ensanut_2018_informe_final.pdf."},{"issue":"15","key":"754_CR22","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","volume":"168","author":"N Stefan","year":"2008","unstructured":"Stefan N. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168(15):1609\u201316. https:\/\/doi.org\/10.1001\/archinte.168.15.1609.","journal-title":"Arch Intern Med"},{"issue":"10","key":"754_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/ejcn.2010.114","volume":"64","author":"S Velho","year":"2010","unstructured":"Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr. 2010;64(10):1043\u201351. https:\/\/doi.org\/10.1038\/ejcn.2010.114.","journal-title":"Eur J Clin Nutr"},{"issue":"47","key":"754_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008838","volume":"96","author":"H Lin","year":"2017","unstructured":"Lin H, Zhang L, Zheng R, Zheng Y. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and meta-analysis: a PRISMA-compliant article. Medicine. 2017;96(47):e8838. https:\/\/doi.org\/10.1097\/MD.0000000000008838.","journal-title":"Medicine."},{"issue":"1","key":"754_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13098-015-0016-5","volume":"7","author":"V Mbanya","year":"2015","unstructured":"Mbanya V, Echouffo-Tcheugui J, Akhtar H, Mbanya J, Kengne A. Obesity phenotypes in urban and rural Cameroonians: a cross-sectional study. Diabetol Metab Syndr. 2015;7(1):21. https:\/\/doi.org\/10.1186\/s13098-015-0016-5.","journal-title":"Diabetol Metab Syndr"},{"issue":"6","key":"754_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.nut.2014.12.024","volume":"31","author":"PA de Castro","year":"2015","unstructured":"de Castro PA, Scorsatto M, Moraes de Oliveira G, Rosa G, Luiz R. Characterization of metabolically healthy obese Brazilians and cardiovascular risk prediction. Nutrition. 2015;31(6):827\u201333.","journal-title":"Nutrition"},{"issue":"1","key":"754_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacc.2014.09.077","volume":"65","author":"J Bell","year":"2015","unstructured":"Bell J, Hamer M, Sabia S, Singh-Manoux A, Batty G, Kivimaki M. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65(1):101\u20132. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.077.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"754_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1530\/EJE-15-0449","volume":"173","author":"M Hamer","year":"2015","unstructured":"Hamer M, Bell J, Sabia S, Batty G, Kivim\u00e4ki M. Stability of metabolically healthy obesity over 8 years: the English longitudinal study of ageing. Eur J Endocrinol. 2015;173(5):703\u20138. https:\/\/doi.org\/10.1530\/EJE-15-0449.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"754_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ijo.2014.113","volume":"39","author":"I Achilike","year":"2014","unstructured":"Achilike I, Hazuda H, Fowler S, Aung K, Lorenzo C. Predicting the development of the metabolically healthy obese phenotype. Int J Obes. 2014;39(2):228\u201334. https:\/\/doi.org\/10.1038\/ijo.2014.113.","journal-title":"Int J Obes"},{"issue":"6","key":"754_CR30","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1210\/jc.2012-4253","volume":"98","author":"F Soriguer","year":"2013","unstructured":"Soriguer F, Guti\u00e9rrez-Repiso C, Rubio-Mart\u00edn E, Garc\u00eda-Fuentes E, Almaraz M, Colomo N, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J Clin Endocrinol Metab. 2013;98(6):2318\u201325. https:\/\/doi.org\/10.1210\/jc.2012-4253.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"754_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","volume":"6","author":"N Eckel","year":"2018","unstructured":"Eckel N, Li Y, Kuxhaus O, Stefan N, Hu F, Schulze M. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90\u2008257 women (the Nurses' health study): 30 year follow-up from a prospective cohort study. Lancet Diab Endocrinol. 2018;6(9):714\u201324. https:\/\/doi.org\/10.1016\/S2213-8587(18)30137-2.","journal-title":"Lancet Diab Endocrinol"},{"issue":"3","key":"754_CR32","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1210\/jc.2018-01321","volume":"104","author":"J Echouffo-Tcheugui","year":"2018","unstructured":"Echouffo-Tcheugui J, Short M, Xanthakis V, Field P, Sponholtz T, Larson M, et al. Natural history of obesity subphenotypes: dynamic changes over two decades and prognosis in the Framingham heart study. J Clin Endocrinol Metab. 2018;104(3):738\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"754_CR33","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1210\/jc.2016-2460","volume":"101","author":"M Mongraw-Chaffin","year":"2016","unstructured":"Mongraw-Chaffin M, Foster M, Kalyani R, Vaidya D, Burke G, Woodward M, et al. Obesity severity and duration are associated with incident metabolic syndrome: evidence against metabolically healthy obesity from the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2016;101(11):4117\u201324. https:\/\/doi.org\/10.1210\/jc.2016-2460.","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"754_CR34","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.jacc.2018.02.055","volume":"71","author":"M Mongraw-Chaffin","year":"2018","unstructured":"Mongraw-Chaffin M, Foster M, Anderson C, Burke G, Haq N, Kalyani R, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857\u201365. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.055.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"754_CR35","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.2337\/dc12-1971","volume":"36","author":"S Appleton","year":"2013","unstructured":"Appleton S, Seaborn C, Visvanathan R, Hill C, Gill T, Taylor A, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388\u201394. https:\/\/doi.org\/10.2337\/dc12-1971.","journal-title":"Diabetes Care"},{"issue":"3","key":"754_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.21149\/8819","volume":"60","author":"C Medina","year":"2018","unstructured":"Medina C, J\u00e1uregui A, Campos-Nonato I. Prevalence and trends of physical activity in children and adolescents: results of the Ensanut 2012 and Ensanut MC 2016. Salud Publica Mex. May-Jun 2018;60(3):263\u201371. https:\/\/doi.org\/10.21149\/8819.","journal-title":"Salud Publica Mex"},{"key":"754_CR37","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1590\/S0036-36342010000700004","volume":"52","author":"R Rojas","year":"2010","unstructured":"Rojas R, Aguilar-Salinas C, Jim\u00e9nez-Corona A, Shamah-Levy T, Rauda J, \u00c1vila-Burgos L, et al. Metabolic syndrome in Mexican adults: results from the National Health and nutrition survey 2006. Salud Publica Mex. 2010;52:S11\u20138. https:\/\/doi.org\/10.1590\/S0036-36342010000700004.","journal-title":"Salud Publica Mex"},{"issue":"7","key":"754_CR38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","volume":"8","author":"N Stefan","year":"2020","unstructured":"Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol. 2020 Jul;8(7):616\u201327. https:\/\/doi.org\/10.1016\/S2213-8587(20)30110-8.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"754_CR39","doi-asserted-by":"publisher","unstructured":"Kim NH, Seo JA, Cho H, Seo JH, Yu JH, Yoo HJ et al. Risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people. Medicine (United States). 2016;95(15). e3384.https:\/\/doi.org\/https:\/\/doi.org\/10.1097\/MD.0000000000003384.","DOI":"10.1097\/MD.0000000000003384"},{"issue":"40","key":"754_CR40","doi-asserted-by":"publisher","first-page":"e1705","DOI":"10.1097\/MD.0000000000001705","volume":"94","author":"S Lee","year":"2015","unstructured":"Lee S, Yang H, Ha H, Lee J, Kwon H, Park Y, et al. Changes in metabolic health status over time and risk of developing type 2 diabetes. Medicine. 2015;94(40):e1705. https:\/\/doi.org\/10.1097\/MD.0000000000001705.","journal-title":"Medicine"},{"issue":"9","key":"754_CR41","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/2047487315623884","volume":"23","author":"N Eckel","year":"2015","unstructured":"Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze M. Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol. 2015;23(9):956\u201366. https:\/\/doi.org\/10.1177\/2047487315623884.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"754_CR42","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00125-018-4787-8","volume":"62","author":"M Schulze","year":"2018","unstructured":"Schulze M. Metabolic health in normal-weight and obese individuals. Diabetologia. 2018;62(4):558\u201366.","journal-title":"Diabetologia"},{"issue":"2","key":"754_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","volume":"26","author":"N Stefan","year":"2017","unstructured":"Stefan N, Schick F, H\u00e4ring H. Causes, characteristics, and consequences of metabolically unhealthy Normal weight in humans. Cell Metab. 2017;26(2):292\u2013300. https:\/\/doi.org\/10.1016\/j.cmet.2017.07.008.","journal-title":"Cell Metab"},{"issue":"3","key":"754_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/jama.2018.8188","volume":"320","author":"R Rubin","year":"2018","unstructured":"Rubin R. What\u2019s the best way to treat Normal-weight people with metabolic abnormalities? JAMA. 2018;320(3):223. https:\/\/doi.org\/10.1001\/jama.2018.8188.","journal-title":"JAMA"},{"key":"754_CR45","volume-title":"La obesidad en M\u00e9xico. Estado de la pol\u00edtica p\u00fablica y recomendaciones para su prevenci\u00f3n y control","author":"CA Aguilar Salinas","year":"2018","unstructured":"Aguilar Salinas CA. Atenci\u00f3n primaria. Modelo de control y atenci\u00f3n a la salud. In: Rivera Dommarco JA, Colchero MA, Fuentes ML, Gonz\u00e1lez de Cos\u00edo Mart\u00ednez T, Aguilar Salinas CA, Hern\u00e1ndez Licona G, Barquera S, editors. La obesidad en M\u00e9xico. Estado de la pol\u00edtica p\u00fablica y recomendaciones para su prevenci\u00f3n y control. Cuernavaca: Instituto Nacional de Salud P\u00fablica, M\u00e9xico; 2018."}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00754-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-021-00754-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00754-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T03:09:48Z","timestamp":1619579388000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00754-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["754"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00754-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"22 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n and all participants signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}